Bertilimumab is a human immunoglobulin monoclonal antibody which targets eotaxin-1, a member of the chemokine family of proteins regulating eosinophilic inflammation. The double-blind, parallel group, randomized, placebo-controlled 90
Under the agreement, GGA will distribute SAR, Biomarker and Clinical Outcomes databases as well as promote the BioIT and Data Curation services offered by GVK. GVK Biosciences informatics
Using Client Outlooks’ eUnity platform, the eHealthViewer ZF solution allows any user to view diagnostic quality medical images securely, with a single click from any health information exchange
The collaboration, which was started in 2010, will work under the guidance of CU School of Medicinepediatrics professor Jan Kraus and includes sponsored-research funding by OT to continue
Suprax oral suspension is indicated for otitis media, acute exacerbation of chronic bronchitis, uncomplicated urinary tract infections, uncomplicated gonorrhea (cervical/urethral) and pharyngitis/tonsillitis. Lupin Group president Vinita Gupta said,
As part of the agreement, both the companies will combine their expertise in the development of new excipients and drug formulations to provide customers from the pharmaceutical industry
The DFS unit will leverage the company’s proprietary technology platforms including lipid-based formulations and targeted release capsule formulation, R&D capabilities and commercial manufacturing infrastructure to develop and manufacture
Under the agreement, Abbott will leverage its proprietary Vysis CLL fluorescence in situ hybridization (FISH) Probe kit to develop a test for identifying high-risk chronic lymphocytic leukemia (CLL)
The failure of hematopoietic stem cells (HSCs) present in the bone marrow to produce red blood cells, white blood cells and platelets, results in aplastic anemia. Pluristem chairman
Advanced HCC patient who did not respond to standard-of-care therapy with sorafenib, was enrolled in the study. GenSpera CEO and president Craig Dionne said, "The scientific rationale for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.